News
IDIBELL is among the 120 top research centers in the world
The Scimago international ranking of Research Institutions places IDIBELL on 115th position among the 500 most highly-rated institutions in the world in all disciplines by its index and normalized impact with an excellence rate of 27.3. The report analyzes the scientific articles published by more than three thousand institutions in 104 different countries between 2005 […]
Ferran Azorín: “Knowledge of basic mechanisms of epigenetics will allow us to develop new therapeutic strategies”
The laboratory of the Molecular Biology Institute of the CSIC in Barcelona led by Ferran Azorin, focuses its research on trying to understand the basic mechanisms that regulate genome function through epigenetics. The researcher has explained its latest advances in this field in the IDIBELL seminar series on November 25. One of the epigenetic factors […]
Jean-Ehrland Ricci: ”We investigate how targeting glycolysis may influence immune response anti-cancer”
The researcher at INSERM (French Institute for Health and Medical Research) Jean-Ehrland Ricci examines the correlation between glycolysis, cell death and immune response in tumor cells. He explained his latest developments in his research on IDIBELL seminar series November 18. Most cancer cells exhibit increased glycolysis for the generation of their energy supply (named the […]
DNA in my pocket
Some forty secondary and high school students of L’Hospitalet have had the opportunity to discover the research of IDIBELL during activities that the center has prepared to celebrate the Week of Science. As if they were real scientists, students carried out an experiment that they can easily repeat at home. They extracted their DNA, their […]
Described a new molecular mechanism altered in breast cancer development
About 10% of breast cancers are due to mutations in genes called BRCA1 and BRCA2. Still, it is not yet fully known the molecular mechanism that explains how the alteration of these genes greatly increases the risk of cancer. An international team led by the researcher of the IDIBELL and the Catalan Institute of Oncology […]
Louis Bouscail: “Our research in gene therapy must advance step by step. Our next challenge is to reach phase II of our clinical trial”
The gastroenterologist of the University Hospital of Rangueil, Touluse, and researcher at INSERM, Louis Buscail explained his latest advances in gene therapy for advanced pancreatic cancer in IDIBELL seminar series on 11 November. Currently, the only effective treatment for pancreatic cancer is surgery. The chemotherapeutic agent gemcitabine improves the survival of the patient but survival […]
La Marató de TV3 finance five projects involving IDIBELL researchers
Five IDIBELL researchers are involved in projects funded by La Marató de TV3, dedicated to spinal cord and acquired brain injuries. They are María Berdasco, research group of Cancer Epigenetics; Artur Llobet, research group of celular and Molecular Neurobiology; Cristina Muñoz Pinedo, head of the research group of Cell Death regulation; Antoni Rodríguez-Fornells, head of […]
The therapeutic videogame realized by IDIBELL researchers, one of the best ideas of the year for ‘Diario Médico’
The IDIBELL and the University Hospital of Bellvitge have received one of the awards to the Best Ideas of the Year, awarded by the newspaper specializing in medicine and health ‘Diario Médico’, for their therapeutic videogame, called Islands, directed to complement the therapy of patients with eating disorders or pathological gambling addiction. This is the […]